All In MedTech

Device Trial Radar · NCT07940036

Skin Cancer Detection in Primary Care With and Without DermaSensor

Improving Skin Cancer Detection With AI-Assisted Triage in Healthcare: A Real-World, Multi-Center, Randomized Controlled Trial (INSIGHT-RCT)

Last checked: Nov 19, 2026Latest source record: Nov 16, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

Not yet recruitingPivotal-lookingRandomized with 200 participants. This is a heuristic, not a regulatory label.

Status

Not yet recruiting

Enrollment

200

Planned (sponsor's estimate)

Start

Nov 10, 2026

Primary completion

Jun 2028

Study completion Jun 2028

Sponsor

Lead sponsor
DermaSensor, Inc.Not on our public-company list
Sponsor type
Industry
First posted
Nov 16, 2026

More device trials from this sponsor

Design

Study type
Interventional
Phase
Not applicable (typical for device studies)
Allocation
Randomized
Model
Parallel
Masking
None
Primary purpose
Health services research
FDA-regulated device
Yes
Who can join
All sexes
Healthy volunteers
Yes

Summary

As written by the sponsor on the registry.

This randomized controlled trial evaluates whether primary care physician access to the DermaSensor device increases the proportion of patients with histopathology-confirmed skin cancer compared with physician standard clinical assessment alone. Participating physicians are randomized and outcomes are drawn from existing electronic health record data for up to 500,000 patient encounters.

Conditions

  • Skin Cancer
  • Basal Cell Cancer
  • Squamous Cell Carcinoma
  • Melanoma (Skin Cancer)
  • Melanoma In Situ
  • Melanoma Detection
  • Melanoma

Interventions

  • DermaSensorDevice

    Handheld device used by primary care physicians as an adjunct to clinical assessment of skin lesions suggestive of skin cancer, per its labeling.

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Proportion of patients with histopathology-confirmed skin cancerTime frame: Within 12 months of the initial primary care visit

Locations

1 site in 1 country. Site status is shown where the registry gives one.

  • SSM Health

    St Louis, Missouri

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.